Arvinas Historical Financial Ratios
| ARVN Stock | USD 8.75 0.25 2.78% |
Arvinas is presently reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.33 or Days Sales Outstanding of 18.04 will help investors to properly organize and evaluate Arvinas financial condition quickly.
Arvinas |
About Arvinas Financial Ratios Analysis
ArvinasFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Arvinas investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Arvinas financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Arvinas history.
Arvinas Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Arvinas stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Arvinas sales, a figure that is much harder to manipulate than other Arvinas multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Most ratios from Arvinas' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Arvinas current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.At this time, Arvinas' Revenue Per Share is very stable compared to the past year.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 22.22 | 33.48 | 18.98 | 18.04 | PTB Ratio | 3.22 | 3.46 | 2.45 | 2.33 |
Arvinas fundamentals Correlations
Click cells to compare fundamentals
Arvinas Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arvinas fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Price To Sales Ratio | 154.01 | 87.94 | 13.85 | 29.1 | 5.23 | 4.97 | |
| Ptb Ratio | 5.23 | 5.25 | 3.22 | 3.46 | 2.45 | 2.33 | |
| Days Sales Outstanding | 16.74 | 200.87 | 22.22 | 33.48 | 18.98 | 18.04 | |
| Book Value Per Share | 16.25 | 15.63 | 10.62 | 11.89 | 7.81 | 7.55 | |
| Free Cash Flow Yield | (0.0346) | (0.0287) | 0.14 | (0.15) | (0.19) | (0.18) | |
| Operating Cash Flow Per Share | (2.27) | 11.19 | (5.14) | (6.27) | (3.61) | (3.43) | |
| Stock Based Compensation To Revenue | 1.39 | 1.22 | 0.57 | 0.91 | 0.33 | 0.52 | |
| Capex To Depreciation | 1.6 | 0.78 | 0.83 | 0.43 | 0.27 | 0.26 | |
| Pb Ratio | 5.23 | 5.25 | 3.22 | 3.46 | 2.45 | 2.33 | |
| Ev To Sales | 127.21 | 85.73 | 13.27 | 25.17 | 4.89 | 4.64 | |
| Free Cash Flow Per Share | (2.43) | 11.09 | (5.27) | (6.32) | (3.63) | (3.45) | |
| Net Income Per Share | (2.83) | (3.66) | (5.11) | (6.62) | (2.77) | (2.9) | |
| Sales General And Administrative To Revenue | 1.76 | 1.32 | 0.61 | 1.28 | 0.63 | 0.72 | |
| Research And Ddevelopement To Revenue | 4.97 | 3.86 | 2.4 | 4.84 | 1.32 | 1.26 | |
| Capex To Revenue | 0.3 | 0.1 | 0.0518 | 0.0369 | 0.006834 | 0.006492 | |
| Cash Per Share | 17.42 | 30.05 | 22.66 | 22.72 | 14.46 | 12.42 | |
| Pocfratio | (37.41) | 7.34 | (6.65) | (6.57) | (5.32) | (5.58) | |
| Interest Coverage | (762.57) | (602.14) | (1.9K) | (21.93) | (25.22) | (26.48) | |
| Capex To Operating Cash Flow | (0.0718) | 0.008402 | (0.0249) | (0.008338) | (0.006942) | (0.007289) | |
| Pfcf Ratio | (34.9) | 7.4 | (6.49) | (6.51) | (5.28) | (5.01) | |
| Income Quality | 0.75 | (2.93) | 0.97 | 0.95 | 1.3 | 1.37 | |
| Roe | (0.17) | (0.23) | (0.48) | (0.56) | (0.35) | (0.37) | |
| Ev To Operating Cash Flow | (30.9) | 7.16 | (6.38) | (5.68) | (4.96) | (5.21) | |
| Pe Ratio | (30.04) | (22.42) | (6.69) | (6.22) | (6.93) | (7.28) | |
| Ev To Free Cash Flow | (28.83) | 7.22 | (6.22) | (5.63) | (4.93) | (4.68) | |
| Earnings Yield | (0.0459) | (0.0333) | (0.0446) | (0.15) | (0.16) | (0.14) | |
| Net Debt To E B I T D A | 4.97 | 0.56 | 0.3 | 0.78 | 0.37 | 0.35 | |
| Current Ratio | 14.32 | 5.93 | 4.2 | 4.98 | 4.64 | 7.19 | |
| Tangible Book Value Per Share | 16.25 | 15.63 | 10.62 | 11.89 | 7.81 | 7.55 | |
| Receivables Turnover | 21.8 | 1.82 | 16.43 | 10.9 | 19.23 | 20.19 | |
| Shareholders Equity Per Share | 16.25 | 15.63 | 10.62 | 11.89 | 7.81 | 7.55 | |
| Debt To Equity | 0.006291 | 0.006396 | 0.009736 | 0.004848 | 0.0162 | 0.0154 | |
| Capex Per Share | 0.16 | 0.094 | 0.13 | 0.0523 | 0.025 | 0.0238 | |
| Graham Net Net | 15.54 | 14.48 | 9.59 | 11.2 | 7.23 | 7.02 | |
| Revenue Per Share | 0.55 | 0.93 | 2.47 | 1.41 | 3.66 | 3.85 | |
| Interest Debt Per Share | 0.23 | 0.14 | 0.1 | 0.33 | 0.0577 | 0.13 | |
| Debt To Assets | 0.005632 | 0.003161 | 0.004335 | 0.002453 | 0.008338 | 0.008052 |
Pair Trading with Arvinas
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arvinas position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arvinas will appreciate offsetting losses from the drop in the long position's value.Moving together with Arvinas Stock
Moving against Arvinas Stock
| 0.72 | OCX | OncoCyte Corp | PairCorr |
| 0.64 | SNY | Sanofi ADR | PairCorr |
| 0.58 | AZN | AstraZeneca PLC ADR | PairCorr |
| 0.55 | GILD | Gilead Sciences | PairCorr |
| 0.55 | GOSS | Gossamer Bio | PairCorr |
The ability to find closely correlated positions to Arvinas could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Arvinas when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Arvinas - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Arvinas to buy it.
The correlation of Arvinas is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Arvinas moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Arvinas moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Arvinas can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Arvinas. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.77) | Revenue Per Share | Quarterly Revenue Growth 1.96 | Return On Assets | Return On Equity |
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.